# NEO-BLAST (NCT06537154)

> NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06537154
- Phase: PHASE2, PHASE3
- Status: RECRUITING
- Sponsor: Peter Black
- Conditions: Muscle-Invasive Bladder Carcinoma
- Interventions: Active Surveillance; Control arm - Definitive bladder treatment
- Enrollment: 688
- Primary outcome: Proportion of patients found to have a cCR and randomized on the number of patients enrolled (pilot-RCT ; phase 2)
- Primary outcome: Metastasis free survival at 2 years (phase 3)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=neo-blast-nct06537154